Aktienanalyse zu Unum Group (UNM)UNMUnum Group

Unum Group is a provider of financial protection benefits in the United States and the United Kingdom. The Company offers disability, life, accident, critical illness, dental and vision, and other related services. Its segments include Unum US, Unum International, and Colonial Life. The Unum US segment comprises group disability, group life and accidental death and dismemberment, and supplemental and voluntary lines of business. It includes long-term and short-term disability, medical stop-loss, and fee-based service products. The Unum International segment includes insurance for group long-term disability, group life, and supplemental lines of business which include dental, individual disability, and critical illness products. The Colonial Life segment includes the accident, sickness, and disability product line, life product line, and cancer and critical illness product line. Its products are marketed to employees, on both a group and an individual basis. It operates in the Financials sector (ACCIDENT & HEALTH INSURANCE industry).

Unum Group is a good buy right now, with a current price of $92.23 and a forward P/E of 8.49, indicating strong valuation compared to earnings expectations. The company also has a solid dividend yield of 2.3%, which is attractive for long-term investors. Despite a cautious full-year EPS guidance of $8.60 to $8.90, the recent earnings report showed an adjusted operating income per share of $2.16, exceeding expectations. The main risk is the lower full-year guidance compared to market expectations, which could impact investor confidence.

13 analysts cover UNM: 3 rate it Buy, 7 Hold and 3 Sell. The average price target is 94.00.